Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-22-084767

SVP, Chief Operating Officer acquired 24,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Korbel Gregory Alan SVP, Chief Operating Officer 2022-07-28 Grant or award +24,300 45,762 D
Derivatives
Korbel Gregory Alan SVP, Chief Operating Officer 2022-07-28 Grant or award · Stock Option (right to Buy) +35,700 35,700 D
Loading xslF345X03/tm2222147-6_4seq1.xml…